haloperidol has been researched along with dinoprostone in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (22.73) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 9 (40.91) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
| Anzini, M; Brogi, S; Butini, S; Campiani, G; Cappelli, A; Caselli, G; Castriconi, F; Gemma, S; Giordani, A; Giorgi, G; Giuliani, G; Lanza, M; Letari, O; Makovec, F; Manini, M; Mennuni, L; Valenti, S | 1 |
| Belyakov, S; Dambrova, M; Kazoka, H; Kuznecovs, J; Lebedev, A; Liepinsh, E; Mishnev, A; Orlova, N; Ponomaryov, Y; Vavers, E; Veinberg, G; Vikainis, S; Vilskersts, R; Vorona, M; Zvejniece, L | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E | 1 |
| Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
| Abiru, T; Kamiya, H; Ono, N; Sugiyama, K | 1 |
| Murray, DW; Rae, T; Rushton, N | 1 |
| Duval, N; Langer, SZ; Massingham, R; Shepperson, NB | 1 |
| Bousquet, E; De Simone, D; Grasso, AA; Millia, CC; Rampello, L; Rapisarda, E; Reggio, A | 1 |
| Condorelli, DF; Costa, G; Grasso, AA; Millia, C; Nicoletti, F; Patti, F; Rampello, L; Rapisarda, E; Scapagnini, U | 1 |
| Asghari, V; Buchwaldt, S; Jovanovic, V; Paterson, A; Sanyal, S; Van Tol, HH | 1 |
| Onoe, H; Osborne, PG; Watanabe, Y | 1 |
| Galmiche, JP; Genève, J; Molis, C; Ropert, A; Rozé, C; Xiaomei, FC | 1 |
| Marroquín, BB; Schäfer, D; Schulze, R; Willershausen, B | 1 |
| Coon, D; Cowan, C; Gulati, A; He, J | 1 |
| Azab, AN; Nassar, A; Sharon-Granit, Y | 1 |
| Acosta, E; Arense, JJ; Catala, M; Cortes, O; Guzman, S; Lorente, M | 1 |
1 trial(s) available for haloperidol and dinoprostone
| Article | Year |
|---|---|
Peptide YY inhibition of prostaglandin-induced intestinal secretion is haloperidol-sensitive in humans.
Topics: Cross-Over Studies; Dinoprostone; Dopamine Antagonists; Double-Blind Method; Eating; Electrolytes; Haloperidol; Humans; Injections, Intramuscular; Injections, Intravenous; Jejunum; Peptide YY; Peptides; Water | 1997 |
21 other study(ies) available for haloperidol and dinoprostone
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
Topics: Animals; Area Under Curve; Humans; Intestinal Absorption; Ligands; Male; Metabolic Clearance Rate; Models, Chemical; Models, Molecular; Molecular Structure; Protein Binding; Protein Structure, Tertiary; Pyrrolidinones; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship | 2013 |
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
Topics: Acetamides; Allosteric Regulation; Animals; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Structure-Activity Relationship | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine | 2016 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |
Influences of cyclooxygenase inhibitors on the cataleptic behavior induced by haloperidol in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aspirin; Catalepsy; Corpus Striatum; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Dopamine; Drug Interactions; Haloperidol; Hydroxyindoleacetic Acid; Indomethacin; Male; Mice; Neurotransmitter Agents; Prostaglandins; Serotonin; Tromethamine | 1992 |
The influence of the surface energy and roughness of implants on bone resorption.
Topics: Animals; Bone Resorption; Cell Adhesion; Cells, Cultured; Dinoprostone; Epoxy Resins; Foreign-Body Reaction; Macrophages; Methylmethacrylates; Mice; Polyethylenes; Polytetrafluoroethylene; Prostheses and Implants; Stainless Steel; Surface Properties | 1989 |
Differential blocking effects of several dopamine receptor antagonists for peripheral pre- and postsynaptic dopamine receptors in the anesthetized dog.
Topics: Anesthesia; Animals; Aporphines; Dinoprostone; Dogs; Epinephrine; Haloperidol; Heart Rate; In Vitro Techniques; Nictitating Membrane; Prostaglandins E; Receptors, Dopamine; Sulpiride; Synapses; Yohimbine | 1982 |
[Effects of dopaminergic drugs on the concentrations of PGE2 and PGF2alpha in various brain regions].
Topics: Animals; Apomorphine; Brain Chemistry; Dinoprost; Dinoprostone; Dopamine; Haloperidol; Male; Prostaglandins E; Prostaglandins F; Rats; Rats, Inbred Strains; Sulpiride | 1983 |
Effects of dopaminergic drugs on cerebellar prostaglandin concentrations.
Topics: Animals; Apomorphine; Brain; Dinoprost; Dinoprostone; Haloperidol; Male; Prostaglandins; Prostaglandins E; Prostaglandins F; Rats; Rats, Inbred Strains; Sulpiride | 1983 |
Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants.
Topics: Animals; Benzamides; Cell Line; CHO Cells; Clozapine; Colforsin; Cricetinae; Cyclic AMP; Dinoprostone; Dopamine; Haloperidol; HeLa Cells; Humans; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Recombinant Proteins; Salicylamides; Spiperone; Transfection | 1995 |
GABAergic system inducing hyperthermia in the rat preoptic area: its independence of prostaglandin E2 system.
Topics: Analysis of Variance; Animals; Bicuculline; Body Temperature; Dinoprostone; Dose-Response Relationship, Drug; Fever; gamma-Aminobutyric Acid; Haloperidol; Male; Microdialysis; Muscimol; Perfusion; Preoptic Area; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Tetrodotoxin; Time Factors | 1994 |
Cytotoxicity of root canal filling materials to three different human cell lines.
Topics: Biocompatible Materials; Biomarkers; Calcium Hydroxide; Cell Division; Cell Line; Cell Survival; Dentin-Bonding Agents; Dinoprostone; Epoxy Resins; Fibroblasts; Gingiva; Glass Ionomer Cements; Gutta-Percha; Humans; Nasal Mucosa; Neoplasms, Glandular and Epithelial; Proteins; Root Canal Filling Materials; Salicylates; Statistics as Topic; Tumor Cells, Cultured | 2000 |
The role of cyclooxygenase-2 (COX-2) in inflammatory bone resorption.
Topics: Acid Phosphatase; Aluminum Compounds; Animals; Biomarkers; Bone Resorption; Calcium Compounds; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Drug Combinations; Epoxy Resins; Female; Gutta-Percha; Inflammation Mediators; Isoenzymes; Lipopolysaccharides; Male; Mice; Mice, Knockout; Osteitis; Osteoblasts; Osteoclasts; Osteoprotegerin; Oxides; RANK Ligand; Root Canal Filling Materials; Silicates; Tartrate-Resistant Acid Phosphatase | 2007 |
Psychotropic drugs attenuate lipopolysaccharide-induced hypothermia by altering hypothalamic levels of inflammatory mediators in rats.
Topics: Animals; Carbamazepine; Dinoprostone; Encephalitis; Haloperidol; Hypothalamus; Hypothermia; Imipramine; Inflammation Mediators; Lipopolysaccharides; Lithium; Male; Neoplasm Proteins; Nucleocytoplasmic Transport Proteins; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2016 |
Relationship between molar incisor hypomineralization, intrapartium medication and illnesses in the first year of life.
Topics: Administration, Intravaginal; Analgesics, Opioid; Anti-Bacterial Agents; Child; Communicable Diseases; Cross-Sectional Studies; Dental Enamel Hypoplasia; Dinoprostone; Female; Haloperidol; Humans; Incisor; Infant; Infant, Newborn; Labor, Induced; Meperidine; Molar; Oxytocics; Pregnancy; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Spain; Time Factors | 2022 |